14-3-3
-
Description Rabbit PolyclonalApplications WB ICC/IFReactivity HuSummary KO/KD validation is based on published data (PMID: 26297806).
$419100μl$16925μl -
$419100μl$16925μl
-
$419100μl$16925μl
-
$419100μl$16925μl
-
Description Rabbit PolyclonalApplications WB IHC-PReactivity HuSummary This antibody was raised against human CD146 Extracellular domain.
$419100μl$16925μl -
Description Mouse MonoclonalApplications WB IPReactivity Species independentSummary This antibody is specific for RFP and does not cross react with GFP.
$419100μl$16925μl -
$419100μl
-
Description Armenian Hamster MonoclonalApplications WB ICC/IF IHC-Fr FCM IP Activation Depletion Neutralizing /InhibitionReactivity Ms
Summary The complete 145-2C11 antibody is commonly used to stimulate T cells in vitro however, when used in vivo activation of resting T cells results in cytokine release and toxicity caused by Ab-mediated cross-linking of T cells and Fcγ receptor-bearing cells. To avoid these complications non-Fc receptor binding F(ab’)2 fragments of the 145-2C11 antibody are commonly used. This non-FcR-binding anti-CD3 induces apoptosis of Ag-activated T cells in vivo by allowing durable expression of the TCR and sustained signaling. Foxp3+ Tregs have been shown to be resistant to CD3 antibody-mediated depletion.
$339500μg -
Description Armenian Hamster MonoclonalApplications WB ICC/IF IHC-Fr FCM IP Activation Depletion Neutralizing /InhibitionReactivity Ms$319250μg
-
Description Rabbit PolyclonalApplications WB IHC-PReactivity HuSummary This antibody was raised against human CD147 Extracellular domain.
$419100μl$16925μl
KO/KD
Carrier-Free
Orthogonal
Overexpression